{
    "2018-05-30": [
        [
            {
                "time": "2018-04-16",
                "original_text": "Avenatti drops bid to represent Stormy Daniels in Trump lawyer Michael Cohen's case",
                "features": {
                    "keywords": [
                        "Avenatti",
                        "Stormy Daniels",
                        "Michael Cohen",
                        "Trump"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-04-17",
                "original_text": "Glaxo/Innoviva File for Approval of Trelegy Ellipta in Japan",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Innoviva",
                        "Trelegy Ellipta",
                        "Japan"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-04-18",
                "original_text": "Michael Cohen's lawyers accuse Stormy Daniels' attorney of 'drive-by shooting' in bank record dump",
                "features": {
                    "keywords": [
                        "Michael Cohen",
                        "Stormy Daniels",
                        "lawyers",
                        "bank record"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-05-02",
                "original_text": "Incyte’s Collaborations and Developments in Q1 2018",
                "features": {
                    "keywords": [
                        "Incyte",
                        "collaborations",
                        "developments",
                        "Q1 2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-05-03",
                "original_text": "How Incyte’s Jakafi Performed in Q1 2018",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Jakafi",
                        "Q1 2018"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-04",
                "original_text": "The Swiss Stock Market Slid Further On Concerns Over Italy",
                "features": {
                    "keywords": [
                        "Swiss Stock Market",
                        "Italy",
                        "concerns"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-05",
                "original_text": "A Look at Incyte’s Product Portfolio in May",
                "features": {
                    "keywords": [
                        "Incyte",
                        "product portfolio",
                        "May"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-05-06",
                "original_text": "Novartis Drug Promacta Gets FDA Priority Review for First-Line SAA",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Promacta",
                        "FDA",
                        "priority review",
                        "SAA"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "2018-05-07",
                "original_text": "FDA Expedites Review Of Novartis' Promacta For First-line Severe Aplastic Anemia",
                "features": {
                    "keywords": [
                        "FDA",
                        "Novartis",
                        "Promacta",
                        "expedited review",
                        "severe aplastic anemia"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}